Ionis Pharmaceuticals
IONS
234 hedge funds and large institutions have $4.52B invested in Ionis Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 85 increasing their positions, 78 reducing their positions, and 21 closing their positions.
110% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 21
10% more funds holding
Funds holding: 213 → 234 (+21)
10% more capital invested
Capital invested by funds: $4.13B → $4.52B (+$393M)
9% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 78
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
33% less call options, than puts
Call options by funds: $92.9M | Put options by funds: $140M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$48.1M |
| 2 |
CCI
Columbus Circle Investors
|
+$45.5M |
| 3 |
SI
Scout Investments
Kansas City,
Missouri
|
+$42M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.7M |
| 5 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$27.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$97.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$61.9M |
| 3 |
VAM
Visium Asset Management
New York
|
-$38.1M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$30.7M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$19.3M |
IONS Hedge Fund Activity: Q1 2014 in Review
234 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q1 2014, worth a combined $4.52B — up 9.5% from $4.13B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new IONS positions and 21 closed out — a net gain of 23 holders — while 85 added to existing stakes and 78 trimmed.
The largest buyer was American Century Companies, adding an estimated $48.1M. The largest seller was Artisan Partners, cutting an estimated $97.6M.
- 234 institutional investors held Ionis Pharmaceuticals (IONS) as of Q1 2014, up from 213 in Q4 2013.
- Funds reported $4.52B of Ionis Pharmaceuticals stock for Q1 2014, up 9.5% quarter-over-quarter.
- 44 funds opened new Ionis Pharmaceuticals positions in Q1 2014 and 21 closed out, a net change of +23 holders.
- The largest Ionis Pharmaceuticals buyer in Q1 2014 was American Century Companies, an estimated $48.1M added.
- The largest Ionis Pharmaceuticals seller in Q1 2014 was Artisan Partners, an estimated $97.6M sold.
Based on aggregated 13F filings for Q1 2014.